skip to main content
Idioma:
Mostrar solo
Refinado por: materia: Middle Aged eliminar
Result Number Material Type Add to My Shelf Action Record Details and Options
1
11 years' follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive early breast cancer: final analysis of the HERceptin Adjuvant (HERA) trial
11 years' follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive early breast cancer: final analysis of the HERceptin Adjuvant (HERA) trial
Material Type:
Artículo 		Añadir a Mi Portal

11 years' follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive early breast cancer: final analysis of the HERceptin Adjuvant (HERA) trial

Cameron, David, Prof ; Piccart-Gebhart, Martine J, PhD ; Gelber, Richard D, PhD ; Procter, Marion, PhD ; Goldhirsch, Aron, MD ; de Azambuja, Evandro, MD ; Castro, Gilberto, MD ; Untch, Michael, MD ; Smith, Ian, MD ; Gianni, Luca, MD ; Baselga, Jose, MD ; Al-Sakaff, Nedal, PhD ; Lauer, Sabine, PhD ; McFadden, Eleanor, MA ; Leyland-Jones, Brian, MBBS ; Bell, Richard, MBBS ; Dowsett, Mitch, PhD ; Jackisch, Christian, MD

The Lancet (British edition), 2017-03, Vol.389 (10075), p.1195-1205 [Revista revisada por pares]

England: Elsevier Ltd

Texto completo disponible

Citas Citado por
2
1423 Pancreaticoduodenectomies for Pancreatic Cancer: A Single-Institution Experience
1423 Pancreaticoduodenectomies for Pancreatic Cancer: A Single-Institution Experience
Material Type:
Artículo 		Añadir a Mi Portal

1423 Pancreaticoduodenectomies for Pancreatic Cancer: A Single-Institution Experience

Winter, Jordan M. ; Cameron, John L. ; Campbell, Kurtis A. ; Arnold, Meghan A. ; Chang, David C. ; Coleman, JoAnn ; Hodgin, Mary B. ; Sauter, Patricia K. ; Hruban, Ralph H. ; Riall, Taylor S. ; Schulick, Richard D. ; Choti, Michael A. ; Lillemoe, Keith D. ; Yeo, Charles J.

Journal of gastrointestinal surgery, 2006-11, Vol.10 (9), p.1199-1211 [Revista revisada por pares]

United States: Elsevier Inc

Texto completo disponible

Citas Citado por
3
2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial
2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial
Material Type:
Artículo 		Añadir a Mi Portal

2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial

Smith, Ian, Prof ; Procter, Marion, MSci ; Gelber, Richard D, Prof ; Guillaume, Sébastien, MSc ; Feyereislova, Andrea, MD ; Dowsett, Mitch, Prof ; Goldhirsch, Aron, Prof ; Untch, Michael, Prof ; Mariani, Gabriella, MD ; Baselga, Jose, Prof ; Kaufmann, Manfred, Prof ; Cameron, David, MD ; Bell, Richard, Prof ; Bergh, Jonas, Prof ; Coleman, Robert, Prof ; Wardley, Andrew, MD ; Harbeck, Nadia, Prof ; Lopez, Roberto I, MD ; Mallmann, Peter, Prof ; Gelmon, Karen, Prof ; Wilcken, Nicholas, PhD ; Wist, Erik, Prof ; Sánchez Rovira, Pedro, MD ; Piccart-Gebhart, Martine J, Prof

The Lancet (British edition), 2007-01, Vol.369 (9555), p.29-36 [Revista revisada por pares]

England: Elsevier Ltd

Texto completo disponible

Citas Citado por
4
2 years versus 1 year of adjuvant trastuzumab for HER2-positive breast cancer (HERA): an open-label, randomised controlled trial
2 years versus 1 year of adjuvant trastuzumab for HER2-positive breast cancer (HERA): an open-label, randomised controlled trial
Material Type:
Artículo 		Añadir a Mi Portal

2 years versus 1 year of adjuvant trastuzumab for HER2-positive breast cancer (HERA): an open-label, randomised controlled trial

Goldhirsch, Aron, Prof ; Gelber, Richard D, Prof ; Piccart-Gebhart, Martine J, Prof ; de Azambuja, Evandro, MD ; Procter, Marion, MSci ; Suter, Thomas M, Prof ; Jackisch, Christian, Prof ; Cameron, David, Prof ; Weber, Harald A, MD ; Heinzmann, Dominik, PhD ; Lago, Lissandra Dal, MD ; McFadden, Eleanor, MA ; Dowsett, Mitch, Prof ; Untch, Michael, Prof ; Gianni, Luca, MD ; Bell, Richard, Prof ; Köhne, Claus-Henning, Prof ; Vindevoghel, Anita, MD ; Andersson, Michael, MD ; Brunt, A Murray, MD ; Otero-Reyes, Douglas, MD ; Song, Santai, MD ; Smith, Ian, Prof ; Leyland-Jones, Brian, PhD ; Baselga, Jose, Prof

The Lancet (British edition), 2013-09, Vol.382 (9897), p.1021-1028 [Revista revisada por pares]

Kidlington: Elsevier Ltd

Texto completo disponible

Citas Citado por
5
6‐Sulfatoxymelatonin excretion and self‐reported sleep in good sleeping controls and 55–80‐year‐old insomniacs
6‐Sulfatoxymelatonin excretion and self‐reported sleep in good sleeping controls and 55–80‐year‐old insomniacs
Material Type:
Artículo 		Añadir a Mi Portal

6‐Sulfatoxymelatonin excretion and self‐reported sleep in good sleeping controls and 55–80‐year‐old insomniacs

LUSHINGTON, KURT ; LACK, LEON ; KENNAWAY, DAVID J ; ROGERS, NAOMI ; VAN DEN HEUVEL, CAMERON ; DAWSON, DREW

Journal of sleep research, 1998-06, Vol.7 (2), p.75-83 [Revista revisada por pares]

Oxford, UK: Blackwell Science Ltd

Texto completo disponible

Citas Citado por
6
6 versus 12 months of adjuvant trastuzumab for HER2-positive early breast cancer (PERSEPHONE): 4-year disease-free survival results of a randomised phase 3 non-inferiority trial
6 versus 12 months of adjuvant trastuzumab for HER2-positive early breast cancer (PERSEPHONE): 4-year disease-free survival results of a randomised phase 3 non-inferiority trial
Material Type:
Artículo 		Añadir a Mi Portal

6 versus 12 months of adjuvant trastuzumab for HER2-positive early breast cancer (PERSEPHONE): 4-year disease-free survival results of a randomised phase 3 non-inferiority trial

Hiller, Louise ; Vallier, Anne-Laure ; McAdam, Karen ; Hughes-Davies, Luke ; Ah-See, Mei-Lin ; Simcock, Richard ; Rea, Daniel ; Raj, Sanjay ; Woodings, Pamela ; Harries, Mark ; Raynes, Kerry ; Higgins, Helen B ; Plummer, Chris ; Mansi, Janine ; Mahler–Araujo, Betania ; Abraham, Jean E ; Caldas, Carlos ; McCabe, Christopher ; Miles, David ; Wardley, Andrew M ; Cameron, David A ; Agarwal, Roshan ; Algurafi, Hafiz ; Archer, Caroline ; Armstrong, Anne ; Bale, Catherine ; Barraclough, Lisa ; Barthakur, Urmila ; Bedi, Carolyn ; Benstead, Kim ; Bloomfield, David ; Bowen, Rebecca ; Bradley, Chris ; Brown, Jane ; Butt, Mohammad ; Churn, Mark ; Cleator, Susan ; Cliff, Joanne ; Crellin, Perric ; Daly, Margaret ; De Silva-Minor, Shiroma ; Dhadda, Amandeep ; Din, Omar ; Down, Sue ; Earl, Helena ; Eaton, David ; Eichholz, Andrew ; Epurescu, Daniel ; Goh, Chee ; Goodman, Andrew ; Grieve, Robert ; Hadaki, Maher ; Harper-Wynne, Catherine ; Harries, Mark ; Hayward, Larry ; Humphreys, Alison ; Innes, Helen ; Jafri, Mariam ; Jegannathen, Apurna ; Kelleher, Muireann ; Kristeleit, Hartmut ; Lee, Daniela ; Lupton, Susan ; MacGregor, Carol ; Malik, Zafar ; Mansi, Janine ; Marshall, Jennifer ; McAdam, Karen ; McGolick, Trevor ; Mehra, Rakesh ; Miles, David ; Mithal, Natasha ; Moss, Charlotte ; Moss, Aian ; Nelmes, Daniel ; Neville-Webbe, Helen ; Newby, Jacqueline ; O'Reilly, Susan ; Ostler, Peter ; Persic, Mojca ; Pettit, Laura ; Raj, Sanjay ; Raja, Fharat ; Rea, Daniel ; Reed, Catherine ; Rigg, Anne ; Roe, Helen ; Shah, Nihal ; Simmonds, Peter ; Sims, Eliot ; Smith, Sarah ; Storey, Nicola ; Taylor, Wendy ; Tipples, Karen ; Vaidya, Jayant ; Varughese, Mohini ; Walji, Nawaz ; Woodings, Pamela ; Wright, Kathryn ; Yahya, Sundus

The Lancet (British edition), 2019-06, Vol.393 (10191), p.2599-2612 [Revista revisada por pares]

England: Elsevier Ltd

Texto completo disponible

Citas Citado por
7
6 versus 12 months of adjuvant trastuzumab for HER2-positive early breast cancer (PERSEPHONE): 4-year disease-free survival results of a randomised phase 3 non-inferiority trial
6 versus 12 months of adjuvant trastuzumab for HER2-positive early breast cancer (PERSEPHONE): 4-year disease-free survival results of a randomised phase 3 non-inferiority trial
Material Type:
Artículo 		Añadir a Mi Portal

6 versus 12 months of adjuvant trastuzumab for HER2-positive early breast cancer (PERSEPHONE): 4-year disease-free survival results of a randomised phase 3 non-inferiority trial

Earl, Helena M ; Hiller, Louise ; Vallier, Anne-Laure ; Loi, Shrushma ; McAdam, Karen ; Hughes-Davies, Luke ; Harnett, Adrian N ; Ah-See, Mei-Lin ; Simcock, Richard ; Rea, Daniel ; Raj, Sanjay ; Woodings, Pamela ; Harries, Mark ; Howe, Donna ; Raynes, Kerry ; Higgins, Helen B ; Wilcox, Maggie ; Plummer, Chris ; Mansi, Janine ; Gounaris, Ioannis ; Mahler-Araujo, Betania ; Provenzano, Elena ; Chhabra, Anita ; Abraham, Jean E ; Caldas, Carlos ; Hall, Peter S ; McCabe, Christopher ; Hulme, Claire ; Miles, David ; Wardley, Andrew M ; Cameron, David A ; Dunn, Janet A ; PERSEPHONE Steering Committee and Trial Investigators

http://dx.doi.org/10.1016/s0140-673630650-6 2019-06

Texto completo disponible

Citas Citado por
8
A 57-Year-Old Man With Insidious Dyspnea and Nonpleuritic Chest and Back Pain
A 57-Year-Old Man With Insidious Dyspnea and Nonpleuritic Chest and Back Pain
Material Type:
Artículo 		Añadir a Mi Portal

A 57-Year-Old Man With Insidious Dyspnea and Nonpleuritic Chest and Back Pain

Nakamura, Kenta, MD ; Alba, George A., MD ; Scheske, Jonathan A., MD ; Meyersohn, Nandini M., MD ; Stone, James R., MD, PhD ; Vlahakes, Gus J., MD ; Wright, Cameron D., MD ; Ghoshhajra, Brian B., MD ; Dudzinski, David M., MD, JD

Chest, 2016-08, Vol.150 (2), p.e41-e47 [Revista revisada por pares]

United States: Elsevier Inc

Texto completo disponible

Citas Citado por
9
Abdominal infections in the intensive care unit: characteristics, treatment and determinants of outcome
Abdominal infections in the intensive care unit: characteristics, treatment and determinants of outcome
Material Type:
Artículo 		Añadir a Mi Portal

Abdominal infections in the intensive care unit: characteristics, treatment and determinants of outcome

De Waele, Jan ; Lipman, Jeffrey ; Sakr, Yasser ; Marshall, John C ; Vanhems, Philippe ; Barrera Groba, Casiano ; Leone, Marc ; Vincent, Jean-Louis

BMC infectious diseases, 2014-07, Vol.14 (1), p.420-420, Article 420 [Revista revisada por pares]

England: BioMed Central Ltd

Texto completo disponible

Citas Citado por
10
Absolute leukocyte telomere length in HIV-infected and uninfected individuals: evidence of accelerated cell senescence in HIV-associated chronic obstructive pulmonary disease
Absolute leukocyte telomere length in HIV-infected and uninfected individuals: evidence of accelerated cell senescence in HIV-associated chronic obstructive pulmonary disease
Material Type:
Artículo 		Añadir a Mi Portal

Absolute leukocyte telomere length in HIV-infected and uninfected individuals: evidence of accelerated cell senescence in HIV-associated chronic obstructive pulmonary disease

Liu, Joseph C Y ; Leung, Janice M ; Ngan, David A ; Nashta, Negar F ; Guillemi, Silvia ; Harris, Marianne ; Lima, Viviane D ; Um, Soo-Jung ; Li, Yuexin ; Tam, Sheena ; Shaipanich, Tawimas ; Raju, Rekha ; Hague, Cameron ; Leipsic, Jonathon A ; Bourbeau, Jean ; Tan, Wan C ; Harrigan, P Richard ; Sin, Don D ; Montaner, Julio ; Man, S F Paul Morris, Alison

PloS one, 2015-04, Vol.10 (4), p.e0124426-e0124426 [Revista revisada por pares]

United States: Public Library of Science

Texto completo disponible

Citas Citado por

Personalizar los resultados

  1. Editar

Refine Search Results

Ampliar mis resultados

  1.   

Mostrar solo

  1. Revistas arbitradas (844)

Fecha de Publicación 

De Hasta
Refinar
  1. Antes de1986  (20)
  2. 1986Hasta1995  (37)
  3. 1996Hasta2004  (119)
  4. 2005Hasta2014  (326)
  5. Después de 2014  (387)
  6. Más opciones open sub menu

Idioma 

  1. Japonés  (152)
  2. Noruego  (4)
  3. Portugués  (2)
  4. Ruso  (1)
  5. Francés  (1)
  6. Más opciones open sub menu

  • Realización: ABCD-USP USP   Logos de Redes Sociales: Freepik

Buscando en bases de datos remotas, por favor espere

  • Buscando por
  • enscope:(USP_VIDEOS),scope:("PRIMO"),scope:(USP_FISICO),scope:(USP_EREVISTAS),scope:(USP),scope:(USP_EBOOKS),scope:(USP_PRODUCAO),primo_central_multiple_fe
  • Mostrar lo que tiene hasta ahora